Table 2.
Outcome type in studies included
| Author | Publication year | Medication outcomes | Clinical outcomes | System outcomes | Implementation outcomes | Other outcomes |
|---|---|---|---|---|---|---|
| Aharaz A. [22] | 2021 | X | X | X | ||
| Ashworth N. [23] | 2021 | X | X | |||
| Balsom C. [24] | 2020 | X | X | |||
| Boyé NDA. [25] | 2017 | X | X | |||
| Campbell NL. [26] | 2019 | X | X | X | ||
| Campbell NL. [27] | 2021 | X | ||||
| Cateau D. [28] | 2021 | X | X | X | X | |
| Cateau D. [29] | 2021 | X | X | X | X | |
| Clyne B. [30] | 2016 | X | X | |||
| Cool C. [31] | 2018 | X | ||||
| Curtin D. [32] | 2020 | X | X | X | ||
| Dalleur O. [33] | 2014 | X | X | |||
| Edey R. [34] | 2019 | X | X | X | X | |
| Eveleigh R. [35] | 2017 | X | X | |||
| Gedde MH. [36] | 2021 | X | X | |||
| Gnjidic D. [37] | 2019 | X | X | |||
| Gulla C. [38] | 2018 | X | X | X | ||
| Hah JM. [39] | 2020 | X | X | |||
| Ee C.[40] | 2018 | X | X | X | X | |
| Kersten H. [41] | 2013 | X | X | |||
| Kua CH. [42] | 2021 | X | X | X | X | |
| Kuntz JL. [43] | 2019 | X | X | |||
| Navy HJ. [44] | 2018 | X | X | |||
| Potter K. [45] | 2016 | X | X | X | ||
| Rieckert A. [46] | 2020 | X | X | X | ||
| Sathienluckana T. [47] | 2018 | X | X | |||
| Smeets CHW. [48] | 2020 | X | X | |||
| Sullivan MD. [49] | 2017 | X | X | X | X | |
| Tannenbaum C. [50] | 2014 | X | ||||
| Tseng ES. [51] | 2021 | X | X | |||
| Van der Meer HG. [52] | 2018 | X | X | |||
| Vicens C. [53] | 2014 | X | X | |||
| Vicens C. [54] | 2016 | X | X | |||
| Wong APY. [55] | 2021 | X | X | X | X | |
| Wouters H. [56] | 2017 | X | X | X | ||
| Zechmann S. [57] | 2020 | X | X | X | X | X |